Melissa Naiman, PhD, EMT-B

has focused her 20-year career on advancing diagnostics in infectious disease and acute care. Her work spans evidence generation, regulatory strategy, and clinical integration of host response biomarkers—offering laboratorians practical insight into how MDW and MeMed BV testing can support faster, more informed infection and sepsis decisions.